Taur Ying, Jenq Robert R, Perales Miguel-Angel, Littmann Eric R, Morjaria Sejal, Ling Lilan, No Daniel, Gobourne Asia, Viale Agnes, Dahi Parastoo B, Ponce Doris M, Barker Juliet N, Giralt Sergio, van den Brink Marcel, Pamer Eric G
Infectious Disease Service, Department of Medicine, and Lucille Castori Center for Microbes, Inflammation and Cancer, Memorial Sloan-Kettering Cancer Center, New York, NY; Weill Cornell Medical College, New York, NY;
Lucille Castori Center for Microbes, Inflammation and Cancer, Memorial Sloan-Kettering Cancer Center, New York, NY; Weill Cornell Medical College, New York, NY; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; and.
Blood. 2014 Aug 14;124(7):1174-82. doi: 10.1182/blood-2014-02-554725. Epub 2014 Jun 17.
Highly diverse bacterial populations inhabit the gastrointestinal tract and modulate host inflammation and promote immune tolerance. In allogeneic hematopoietic stem cell transplantation (allo-HSCT), the gastrointestinal mucosa is damaged, and colonizing bacteria are impacted, leading to an impaired intestinal microbiota with reduced diversity. We examined the impact of intestinal diversity on subsequent mortality outcomes following transplantation. Fecal specimens were collected from 80 recipients of allo-HSCT at the time of stem cell engraftment. Bacterial 16S rRNA gene sequences were characterized, and microbial diversity was estimated using the inverse Simpson index. Subjects were classified into high, intermediate, and low diversity groups and assessed for differences in outcomes. Mortality outcomes were significantly worse in patients with lower intestinal diversity; overall survival at 3 years was 36%, 60%, and 67% for low, intermediate, and high diversity groups, respectively (P = .019, log-rank test). Low diversity showed a strong effect on mortality after multivariate adjustment for other clinical predictors (transplant related mortality: adjusted hazard ratio, 5.25; P = .014). In conclusion, the diversity of the intestinal microbiota at engraftment is an independent predictor of mortality in allo-HSCT recipients. These results indicate that the intestinal microbiota may be an important factor in the success or failure in allo-HSCT.
胃肠道中栖息着高度多样化的细菌群体,它们可调节宿主炎症并促进免疫耐受。在异基因造血干细胞移植(allo-HSCT)中,胃肠道黏膜受损,定植细菌受到影响,导致肠道微生物群受损且多样性降低。我们研究了肠道多样性对移植后后续死亡率的影响。在干细胞植入时,从80名allo-HSCT受者中采集粪便样本。对细菌16S rRNA基因序列进行表征,并使用反向辛普森指数估计微生物多样性。将受试者分为高、中、低多样性组,并评估结果差异。肠道多样性较低的患者死亡率结果明显更差;低、中、高多样性组3年总生存率分别为36%、60%和67%(P = .019,对数秩检验)。在对其他临床预测因素进行多变量调整后,低多样性对死亡率有很强的影响(移植相关死亡率:调整后的风险比,5.25;P = .014)。总之,植入时肠道微生物群的多样性是allo-HSCT受者死亡率的独立预测因素。这些结果表明,肠道微生物群可能是allo-HSCT成败的重要因素。